Receive up-to-the-minute news updates on the hottest topics with NewsHub. Install now.

FDA staff raises safety concerns over Trevena opioid drug

October 9, 2018 12:33 PM
35 0

(Reuters) - Staff reviewers of the U.S. Food and Drug Administration on Tuesday raised safety concerns over Trevena Inc’s opioid injection to treat acute pain, saying the treatment has an abuse and overdose potential.

The treatment, oliceridine, aims to manage moderate-to-severe acute pain in adult patients for whom an intravenous opioid is warranted.

Also read: FDA approves Pfizer's drug for advanced breast cancer

Read more

Share in social networks:

Comments - 0